Consensus statement and clinical recommendations on the practical management of lipid-lowering therapy in stroke and transient ischaemic attack

This publication has 52 references indexed in Scilit:

• Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field
  Current Atherosclerosis Reports, 2025
• Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11
  American Journal of Preventive Cardiology, 2023
• Organización y costes de la atención extrahospitalaria del ictus. Revisión sistemática de la literatura
  Atencion Primaria, 2023
• Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
  Cardiovascular Drugs and Therapy, 2022
• Lipid-Modifying Therapies and Stroke Prevention
  Current Neurology and Neuroscience Reports, 2022
• Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
  BioDrugs, 2019
• Impact of Lipids on Cardiovascular Health
  JACC, 2018
• Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels
  JAMA Cardiology, 2018
• Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
  JAMA, 2016
• Economic impact of patients admitted to stroke units in Spain
  The European Journal of Health Economics, 2016